Positioning Cloning of Lung Cancer Modifier Gene Par2
肺癌修饰基因Par2的定位克隆
基本信息
- 批准号:7238024
- 负责人:
- 金额:$ 32.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-11 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:A/J MouseAllelesBALB/cByJ MouseBALB/cJ MouseBackcrossingsBiological AssayCancer-Predisposing GeneCandidate Disease GeneChemicalsChromosomes, Human, Pair 18CloningCodeComplementary DNACongenic StrainDNA SequenceDatabasesDevelopmentDiagnostic Neoplasm StagingEnvironmental Risk FactorGenesGeneticGenetic HeterogeneityGenetic PolymorphismGenetic Predisposition to DiseaseGenomicsGoalsHomologous GeneHumanHuman IdentificationsInbred MouseIndividualKnock-in MouseLeadLungLung AdenomaLung NeoplasmsMalignant neoplasm of lungMapsMouse StrainsMusNamesNeoplasmsPositioning AttributePredispositionProductionQuantitative Trait LociResearchResistanceRoleSeriesSmokeStudy modelsSusceptibility GeneTumor stageVariantbasechemical carcinogencongenicenvironmental agentgene environment interactiongenome databaselung carcinogenesismouse modelpositional cloningresponsesizetumor
项目摘要
DESCRIPTION (provided by applicant): The goal of this proposal is to identify the Par2 gene, which is responsible for lung tumor resistance in the BALB/cByJ mouse to chemical carcinogens. Although lung cancer is largely associated with smoking, there is strong evidence for genetic susceptibility and gene-environment interactions in the development of lung cancer. Inbred mouse models offer an effective means of identifying candidate lung cancer modifiers since genetic heterogeneity and enormous variation in exposure levels to environmental agents makes it difficult to identify lung cancer susceptibility loci in humans. A major quantitative trait loci (QTL) locus named pulmonary adenoma resistance gene 2 (Par2) responsible for 50% of variance in tumor multiplicity between the A/J mouse and the BALB/cByJ mouse has been mapped to mouse chromosomes 18. The QTL mapping result has been confirmed by the production of congenic strains in which high lung tumor susceptibility (A/J) allele was substituted onto the genetic background of the BALB/cJ mouse. In this proposal, we will fine map the Par2 QTL by progressively reducing the QTL region through the production of subcongenic mouse strains to narrow it to a size of around 0.2-0.5 cM. DNA sequences of the entire narrowed region will be obtained through completed mouse genomic databases. New and known genes in the target region will be identified and candidate genes will be sought based on known or deduced function and/or differences in expression between A/J mice and BALB/cJ mice. The functional role of the candidate Par2 gene will then be evaluated by constructing knock-in mice with the A/J Par2 allele replacing the BALB/cJ allele. The resulting mouse will be subjected to lung carcinogenesis assay to confirm the Par2 gene. Since the Par2 has been shown to be a negative modifier of the Pas1 QTL, we will produce double congenic strains that contain the Par2 locus in the presence or absence of the Pas1 locus. Comparisons of lung tumor response among double and single congenics will allow definition of interactions between the loci involved. The significance of these studies is that they will identify the Par2 gene whose human homologue may predispose some individuals to lung cancer.
描述(由申请方提供):本提案的目的是鉴定Par 2基因,该基因负责BALB/cByJ小鼠肺肿瘤对化学致癌物的耐药性。虽然肺癌在很大程度上与吸烟有关,但有强有力的证据表明肺癌的发生与遗传易感性和基因-环境相互作用有关。近交系小鼠模型提供了一种有效的手段,确定候选人肺癌改性剂,因为遗传异质性和巨大的变化,暴露水平的环境因素,使其难以确定肺癌易感基因座在人类。一个主要的数量性状基因座(QTL)位点命名为肺腺瘤抗性基因2(Par 2)负责50%的变异之间的肿瘤多样性的A/J小鼠和BALB/cByJ小鼠已被定位到小鼠染色体18。QTL定位结果已被证实的同源株的生产,其中高肺肿瘤易感性(A/J)等位基因被替换到BALB/cJ小鼠的遗传背景。在这个提议中,我们将通过生产亚同源小鼠品系逐步减少QTL区域,将其缩小到约0.2-0.5 cM的大小,从而精细定位Par 2 QTL。整个缩小区域的DNA序列将通过完整的小鼠基因组数据库获得。将鉴定靶区域中的新的和已知的基因,并基于已知或推导的功能和/或A/J小鼠和BALB/cJ小鼠之间的表达差异寻找候选基因。然后通过构建具有A/J Par 2等位基因替换BALB/cJ等位基因的敲入小鼠来评估候选Par 2基因的功能作用。将对所得小鼠进行肺癌发生试验以确认Par 2基因。由于Par 2已被证明是Pas 1 QTL的负修饰子,我们将产生在Pas 1基因座存在或不存在的情况下含有Par 2基因座的双同源菌株。双基因组和单基因组之间肺肿瘤反应的比较将允许定义所涉及的基因座之间的相互作用。这些研究的意义在于,它们将确定Par 2基因,其人类同源物可能使某些个体易患肺癌。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Degradation of lung adenoma susceptibility 1, a major candidate mouse lung tumor modifier, is required for cell cycle progression.
肺腺瘤敏感性 1 是一种主要的候选小鼠肺肿瘤调节因子,其降解是细胞周期进展所必需的。
- DOI:10.1158/0008-5472.can-07-2574
- 发表时间:2007
- 期刊:
- 影响因子:11.2
- 作者:Liu,Yan;Vikis,HarisG;Yi,Yijun;Futamura,Manabu;Wang,Yian;You,Ming
- 通讯作者:You,Ming
Large-scale in silico mapping of complex quantitative traits in inbred mice.
在近交小鼠中复杂定量性状的大规模硅映射。
- DOI:10.1371/journal.pone.0000651
- 发表时间:2007-07-25
- 期刊:
- 影响因子:3.7
- 作者:Liu, Pengyuan;Vikis, Haris;Lu, Yan;Wang, Daolong;You, Ming
- 通讯作者:You, Ming
Five loci, SLT1 to SLT5, controlling the susceptibility to spontaneously occurring lung cancer in mice.
五个基因座,SLT1 至 SLT5,控制小鼠对自发性肺癌的易感性。
- DOI:10.1158/0008-5472.can-05-1508
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Wang,Daolong;You,Ming
- 通讯作者:You,Ming
Identification of Las2, a major modifier gene affecting the Pas1 mouse lung tumor susceptibility locus.
- DOI:10.1158/0008-5472.can-09-0782
- 发表时间:2009-08
- 期刊:
- 影响因子:11.2
- 作者:Pengyuan Liu;H. Vikis;Michael R. James;Yan Lu;Dao-long Wang;Hongbo Liu;Weidong Wen;Yian Wang;M. You
- 通讯作者:Pengyuan Liu;H. Vikis;Michael R. James;Yan Lu;Dao-long Wang;Hongbo Liu;Weidong Wen;Yian Wang;M. You
Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor.
顺式调节XRN2表达的遗传变异有助于自发肺肿瘤的风险。
- DOI:10.1038/onc.2009.396
- 发表时间:2010-02-18
- 期刊:
- 影响因子:8
- 作者:Lu Y;Liu P;James M;Vikis HG;Liu H;Wen W;Franklin A;You M
- 通讯作者:You M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MING YOU其他文献
MING YOU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MING YOU', 18)}}的其他基金
IGF::OT::IGF LUNG CANCER CHEMOPREVENTION BY MICRORNA DELIVERY
通过 MICRORNA 递送进行 IGF::OT::IGF 肺癌化学预防
- 批准号:
9356882 - 财政年份:2016
- 资助金额:
$ 32.28万 - 项目类别:
TARGETED, LABEL-FREE PROTEOMIC ANALYSIS OF URINE IN A RAT BLADDER CANCER MODEL
对大鼠膀胱癌模型中的尿液进行有针对性的、无标记的蛋白质组学分析
- 批准号:
8361368 - 财政年份:2011
- 资助金额:
$ 32.28万 - 项目类别:
TARGETED, LABEL-FREE PROTEOMIC ANALYSIS OF URINE IN A RAT BLADDER CANCER MODEL
对大鼠膀胱癌模型中的尿液进行有针对性的、无标记的蛋白质组学分析
- 批准号:
8168722 - 财政年份:2010
- 资助金额:
$ 32.28万 - 项目类别:
Chemoprevention of lung cancer with red ginseng extracts
红参提取物对肺癌的化学预防
- 批准号:
8324234 - 财政年份:2009
- 资助金额:
$ 32.28万 - 项目类别:
TARGETED, LABEL-FREE PROTEOMIC ANALYSIS OF URINE IN A RAT BLADDER CANCER MODEL
对大鼠膀胱癌模型中的尿液进行有针对性的、无标记的蛋白质组学分析
- 批准号:
7953950 - 财政年份:2009
- 资助金额:
$ 32.28万 - 项目类别:
Chemoprevention of lung cancer with red ginseng extracts
红参提取物对肺癌的化学预防
- 批准号:
8133545 - 财政年份:2009
- 资助金额:
$ 32.28万 - 项目类别:
Chemoprevention of lung cancer with red ginseng extracts
红参提取物对肺癌的化学预防
- 批准号:
7936365 - 财政年份:2009
- 资助金额:
$ 32.28万 - 项目类别:
Chemoprevention of lung cancer with red ginseng extracts
红参提取物对肺癌的化学预防
- 批准号:
7777978 - 财政年份:2009
- 资助金额:
$ 32.28万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 32.28万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 32.28万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 32.28万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 32.28万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 32.28万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 32.28万 - 项目类别: